😀📰 Impartial, trustworthy news that's actually enjoyable to read.
No jargon, bias, or sensationalized info not worthy of your time. Join 175,000+ other readers and get fast, witty updates from DC to Wall Street to Silicon Valley, for free.👇
Join 175,000+ readers. 100% free, unsubscribe anytime
👋 Welcome! The news awaits...
Science & Emerging Tech
| August 20, 2026First-of-its-kind mRNA cancer vaccine passes major test
A personalized cancer vaccine from Moderna and Merck succeeded in preventing melanoma from returning or spreading in a late-stage study of high-risk patients, marking the first successful late-stage trial for a personalized mRNA cancer therapy.
Business & Markets
| August 20, 2026It’s a small-project summer, according to Home Depot
Americans may not be remodeling the kitchen, but that crooked cabinet door has officially run out of excuses, per Home Depot’s latest earnings report.